1.Anaplastic large cell lymphoma associated with tuberculoid granulomatous reaction: report of a case.
Chinese Journal of Pathology 2006;35(2):124-125
Aged
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Cyclophosphamide
;
administration & dosage
;
Doxorubicin
;
administration & dosage
;
Female
;
Granuloma
;
drug therapy
;
immunology
;
pathology
;
Humans
;
Ki-1 Antigen
;
analysis
;
Lymphoma, Large-Cell, Anaplastic
;
drug therapy
;
immunology
;
pathology
;
Vincristine
;
administration & dosage
3.Neonatal Mobius syndrome.
Yi YUAN ; You CHEN ; Shang-ming HUANG
Chinese Journal of Pediatrics 2005;43(7):543-544
4.Thymic carcinoid: report of a case.
Chinese Journal of Pathology 2010;39(9):638-639
Carcinoid Tumor
;
metabolism
;
pathology
;
surgery
;
Female
;
Humans
;
Middle Aged
;
Phosphopyruvate Hydratase
;
metabolism
;
Synaptophysin
;
metabolism
;
Thymectomy
;
Thymus Neoplasms
;
metabolism
;
pathology
;
surgery
6.Thirteen cases of yawn symptom treated by Sun's transcranial repeat stimulation.
Yan-Jie SHANG ; Hao WU ; Yu-Ming WANG
Chinese Acupuncture & Moxibustion 2014;34(3):292-292
Acupuncture Therapy
;
Adolescent
;
Adult
;
Female
;
Humans
;
Male
;
Middle Aged
;
Respiration Disorders
;
physiopathology
;
therapy
;
Yawning
;
Young Adult
7.Value of Serum Soluble Transferrin Receptor in Diagnosis of Iron Deficiency Anemia
hong, SUN ; sha, CHEN ; shang-you, YOU ; yu-ming, GE
Journal of Applied Clinical Pediatrics 2006;0(21):-
Objective To investigate the diagnostic value of serum soluble transferrin receptor(sTfR) in children with iron deficiency anemia(IDA).Methods Sixty-three children with microcytic hypochromic anemia were divided into IDA and non-IDA(n-IDA)groups,on which sTfR and other iron metabolism related indexes such as serum ferritin(SF) and serum iron(SI) were measured,and(t-test) between groups and analysis of ROC curve were carried out.Results The mean concentration of sTfR in the group of IDA was above normal value and t-test difference was extremely significant compared with n-IDA group(P
8.Clinical study of somatostatin combined with raw vegetable oil in treatment of intestinal obstruction
Binfeng WANG ; Ming DING ; Peng SHANG ; Jianhua WANG ; Miaomiao MA
International Journal of Surgery 2016;43(7):466-469
Objective To evaluate the clinical effects and adverse reaction of somatostatin combined with raw vegetable oil in treatment of intestinal obstruction From Tongchuan City People's Hospital were conducted through clinical medication.Methods From August 2012 to August 2015,A total of 364 cases of intestinal obstruction were randomly divided into observation group (182 cases) and control group (182 cases).Two groups were treated with the non-surgical treatment based on basic therapy,including gastrointestinal decompression,correctional of water,electrolyte disturbance and acid-base imbalance to prevent infection and toxication by sedative and spasmolytic.The non-surgical treatment was invalid or worse,the surgical treatment wasselected.Additionally,on the basis of non-surgical treatment,somatostatin combined with raw vegetable oil was additional treatment for the observation group.The comparison of thecurative effect,surgical treatment rate,gastrointestinal decompression,hospital stays and adverse reaction of two groups was conducted.Results The curative effect of observation group (80.22%)was superior to control group(68.68%).Compared to control group,the cases of adverse reaction in observation group was insignificantly increased (x2 =8.58,P < 0.05).Conversely,the observation group showed lower surgical treatment rate (29.67% vs 40.11%,x2 =4.37,P < 0.05),lower gastrointestinal decompression [(224 ± 171) ml/d vs (543 ± 186) ml/d,t =-21.28,P <0.05)],and less hospital stays [(6.14 ± 2.04) d vs (10.26 ± 3.12) d,t =-4.78,P < 0.05)].Conclusions The basic therapy and somatostatin combined with raw vegetable oil showed high efficiency,and cases of adverse reaction was insignificantly increased.It was worthy of promotion and application.
9.Effect of Glycyrrhiza flavonoids on DNA and RNA in tumor cell of S_(180) and H_(22) tumor-bearing mice
Yubin JI ; Wei JIANG ; Ming SHANG ; Hongliang WANG
Chinese Traditional and Herbal Drugs 1994;0(10):-
Objective To observe effects of Glycyrrhiza flavonoids on DNA and RNA in tumor cell of S_(180) and H_(22) tumor-bearing mice.Methods S_(180) and H_(22) mice were randomly divided into Glycyrrhiza flavonoids(25,11.25,and 5.58 mg/kg) groups,positive control(cytoxan 25 mg/kg) group,and negative control(NS) group,whom were given drugs by sc.DNA and RNA in tumor cells were examined,respectively by Laser Scanning Confocal Microscope and fluorescent probe of acridine orange(AO) technology.Results All different dosage of Glycyrrhiza flavonoids,cytoxan reduced the brightness of fluorescence of DNA and RNA;low and high dosage of Glycyrrhiza flavonoids had no significant effect on the fluorescence pixels of RNA/DNA;Both middle dosage of Glycyrrhiza flavonoids and cytoxan had significant effect on the fluorescence pixels of RNA/DNA(P
10.Clinical study of sorafenib for patients with advanced renal cell carcinoma
Ming GAO ; Huijie FAN ; Yanru QIN ; Yuhong SHANG ; Li XU
Chinese Journal of Urology 2013;(5):340-342
Objective To evaluate the efficacy and safety of sorafenib in the treatment of advanced renal cell carcinoma.Methods The clinical date of 33 patients with advanced renal cell carcinoma from September 2007 to April 2012 was reviewed retrospectively.26 were males and 7 were females,with an average age of 69 years.Pathological diagnosis showed 30 clear cell RCCs,2 papillary RCCs,and 1 unclassified RCC.These patients were treated by sorafenib 400 mg twice a day until intolerable toxicity or disease progression.The primary end points were objective response rate,clinical benefit rate,median survival time,median progression-free survival and the incidence of adverse reaction.Results All patients were evaluable for response and toxicity,with 8 patients (24%) of partial remission,19 cases (58%) of stable disease,and 6 cases (18%) of disease progression.The disease control rate was 82%,the median progression-free survival was 10.2 months,while the median survival time was 16.5 months.The common adverse reactions included hand-foot skin reaction (61%),diarrhea (46%),hypertension (21%).Most adverse reactions occurred around the second week after drug therapy,with the duration unequal.The majority of adverse reactions could be released by symptomatic treatment,which did not affect the medication.Conclusion Sorafenib has good short term efficacy for patients with advanced renal cell carcinoma,and most adverse reactions were tolerable.